chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt with hx of anxiety and ADHD, received her dose 2 of moderna vaccine. During observation, pt reported to staff she was having "hard time breathing" @15:15.   Taken to triage area were vitals were taken.  O2 sat on RA 87%,which quickly corrected with supplemental oxygen. Vitals were stable throughout. She was observed for 30 minutes, during which time she had 5 episodes of intermittent tachypnea, c/o feeling hot, dizzy and chest tightness. No rash/hives/stridor/wheezing noted.  Reported during first dose she had "fever, HA, hallucinations, loss of taste and smell the following day".  Pt given water. She was given 2 puffs of albuterol inhaler without significant improvement at 15:45.  Given no notable resolution of her cyclic tachypnea, EMS was called at 15:50. Care was transferred to EMS at 15:53.
Breakthrough case admission after two vaccines Pfizer 3/15/21 Lot# EN6207;  Pfizer 4/6/21 Lot# ER8733
13JUn onset joint pain & numbness in arms & legs, dizziness & fatigue; 16JUN noted red rash on face, swelling in lt leg & fluid on lt knee; by afternoon both legs were very swollen; pt unable to walk w/o crutches;
Nausea, fever, chills, aches and pains, fatigue, headache, neck ache, ear pain, swollen lymph nodes, sore arm. These symptoms lasted about 2 days total.
12 hrs after injection i began to have chills and minor muscle aches and fever of 101F.  These lasted 22 hrs.
I had a runny nose head, it felt like a cold. I used a home COVID-19 test as I knew I had been exposed to COVID-19; it was positive. I called the doctor had him prescribe PAXLOVID. I was feeling better within three days. My wife and were amazed that at time that I had COVID-19 she did not test positive. I also did not test positive when she had it in the summer.
Large reddened area that covers most of anterior left thigh with small blisters in center at site of needle insertion.
Information has been received from a mother regarding her 20 year old daughter with a history of feeling sick after a tetanus shot who in approximately 2007 was vaccinated with a second 0.5 ml dose of GARDASIL. Concomitant therapy included hormonal contraceptives (unspecified). Subsequently she developed a rash. It was unknown if the patient recovered. On 04-OCT-2007 she Received a third 0.5 ml dose of GARDASIL. On 04-OCT-2007 the patient developed vomiting, nausea and a rough, blistery patch near injection site (but not at the injection site). As of 05-OCT-2007 she was recovering. The patient sought unspecified medical attention. Additional information has been requested.
Extreme headache beginning 2 days after vaccine was administered. Accompanied by chills and tiredness, and blurred vision. Today is the 6th day after the vaccine was administered and still have extreme fatigue and moderate headache.
I had burning eyes, blinding headache, chills, body aches, fever of 100, and running nose. I tested positive for COVID-19 at home. I called my doctor, and he prescribed me Paxlovid. I was sick for 2 weeks, but I believe the Paxlovid helped with my symptoms. I also got a sinus infection right after having COVID-19.
This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 76-year-old female patient who received Shingrix for prophylaxis. On 7th May 2018, the patient received the 1st dose of Shingrix. On 8th May 2018, 1 days after receiving Shingrix, the patient experienced fatigue, chills, malaise, fever and upset stomach. On an unknown date, the outcome of the fatigue, chills, malaise, fever and upset stomach were recovered/resolved. It was unknown if the reporter considered the fatigue, chills, malaise, fever and upset stomach to be related to Shingrix. Additional details were provided as follows: The patient received Shingrix on left arm. The patient stated that the symptoms started to resolve 2 days after receiving the Shingrix. The patient did not visit the doctor for these symptoms. For tolerance to the next dose, refer case US2018174563.
feeling unwell; sick to stomach; vomiting; chest pains; hard to breath; chills/freezing; weak; 104 fever; sore arm; sore muscles; This is a spontaneous report received from a contactable consumer (patient's mother). A 18-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 22Mar2021 14:00 (02:00 PM) (Lot Number: EP6955) at the age of 18 years old as single dose for covid-19 immunisation. Medical history included Known allergies Morphine and sulfa antibiotics; Marphans syndrome, autistic, severe scoliosis & kyphosis. The patient's concomitant medications received within 2 weeks of vaccination included too many to put down here not enuf room. Facility where the most recent COVID-19 vaccine was administered at Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The mother took care of the patient due to his sever disability iam filling this out for his as he was unable so he received shot (pending clarification), registered with v-safe, 22Mar2021 2pm. Fine, health check next 23Mar2021 day sore arm, kinda sore muscles, 24Mar2021, sore arm still sore muscles, 25Mar2021 13:00 (1pm), feeling unwell, sick to stomach started vomiting, chest pains, hard to breath, called 911 EMS advised him to stay home after vitals ok due to not wanting to expose the patient to actual Covid virus. At the time no fever 30 min after EMS left 104 fever sever chills, freezing coming in waves so weak. He can't get up to go to the bathroom. The reporter was worried and closely monitoring him. Treatment was received for the adverse event included Medication for vomiting, doctor apt in morning. The events were non-serious per the reporter. The patient underwent lab tests and procedures which included body temperature: no fever 25Mar2021, 104 30 min after EMS left on 25Mar2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was not recovered.
Two days after administration, patient developed pain in his neck similar to "kink" in his neck.  Used topical Lidocaine.  Has not helped.  The "kink" in his neck continues until the date of this report 2/8/2021.
Soon after receiving vaccination, I would experience severe joint pain that would come and go. My right leg feels very weak most of the time. Driving becomes difficult because my hands and feet tingle and go numb sometimes. Fatigue makes it hard to work. My eyesight has gotten worse/noticeable and my cognitive skills are terrible. Ongoing.
vaccine in an unknown thigh; cellulitis; This case was reported by a other health professional via sales rep and described the occurrence of cellulitis in a patient who received DTPa-IPV (Kinrix) (batch number D24G7, expiry date 4th June 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 12th July 2021, the patient received Kinrix (intramuscular) and Kinrix Pre-Filled Syringe Device. On 12th July 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced vaccine administered at inappropriate site. In July 2021, the patient experienced cellulitis (serious criteria GSK medically significant). On an unknown date, the outcome of the cellulitis and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the cellulitis to be related to Kinrix and Kinrix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Kinrix in an unknown thigh which led to vaccine administered at inappropriate site.  Less than a week after receiving Kinrix, the patient developed cellulitis.  No other information was shared. The reporter consented to follow up. The reporter and healthcare professional gave permission to contact them for further information. This is 1 of 4 linked cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR154890:Same reporter US-GLAXOSMITHKLINE-US2021AMR154891:Same reporter US-GLAXOSMITHKLINE-US2021AMR154892:same reporter
Ankle started tightening up Wed evening.  When I woke up on Thursday it was swollen and painful, unable to weightbear or dorsiflex due to pain.  Appears to be an acute tendonitis of right flexor hallucis longus tendon.  I was on crutches for a week before being able to wean off of crutches and return to walking normally.
After 1st dose of the COVID vaccine on 03/19/2021 I had a reaction to the vaccine on 03/26/2021. the vaccinated area started feeling sore, the area had a 2 inch red oval area that itched. 2 days later the soreness, red area and itching stopped. After 2nd dose of COVID vaccine on 04/16/2021 given at 9:15 AM. I had a reaction to the vaccine on 04/16/2021 starting at 7:30 PM. I became nauseas and started to develop a fever that reached 102. The following morning  04/17/2021 I still was nauseas with a fever of 101.  By noon all symptoms were gone. No problems since.
She got her 3rd vaccine, a couple of days later she noticed some burning in her right breast, not knowing where it was coming from around the nipple area.  A few days later she scratched her chest and noticed some abrasions and noticed a rash.  She started to treat that, and then by the 10th or 11th, it started spreading all over her body.  On the 13th she was told to stop taking the Hydroxychloroquine and put on steroids and to see the dermatologist.  She saw the dermatologist and continued to spread.  She went to the ER on the 20th, and was admitted for observation and was released on 9/23/21 and they increased her steroids.   She still has the rash, some has subsided and some areas continue to spread.  She went to the PCP on Friday and derm on Wednesday and has an appointment today with the dermatologist and has been in and out of the doctors office since the vaccine.    Her Rheumatologist told her to get the 3rd vaccine as she has lupus and that she needed it.  Her first vaccine was on 3/21/21, Moderna LOT#003B21A.    She contacted Moderna on Friday, severe report incident.  She also spoke with them on Monday, and told her that they do not reach out to people, which she is not happy with that info.
I was given Pneumococcal Vaccine 23-Valent on August 2, 2017. In 4 hours, I had a golf ball size area just below site of injection. Four days later (August 6, 2017 ) side effect of this drug have moved almost to wrist area. I have experienced these side effects: redness, much swelling almost to wrist, areas itch, much pain, rash and tenderness to touch, and discoloration (yellow) on underside of elbow, and some joint pain. I have been unable to sleep and have to elevate arm. The affected area was also underneath armpit. I was not told of any side-effects, and I would definitely NOT take this vaccine had I know about these side-effects. I had Pneumococcal 13 in 2012 and had no side-effects. These are the worst side-effects I have ever had. I am a healthy female, age 70, do not take any medications for any health issues. Thank you.
Enlargement, redness, stiffness, pain, moderately limits activity at the injection site.
1-1 1/2 hr p/vax devel cough, wheeze, mucous production, resp distress;ER visit, aerosol rx;
Rash around injection site, was originally bumpy but subsided to smooth after the use of hydrocortisone cream. Rash developed on the injection site 7 days after 1st dose of Moderna. I had gone swimming the day the redness began which may have triggered the response. Additional small rashes arose on my forearm but quickly subsided with cortisone cream. However, rash on the injection site persists despite the use of hydrocortisone cream.  Redness and warmth persist. Doctor has prescribed antibiotics in case of skin infection and zyrtec.
lymph nodes to hurt; This case was reported by a consumer via interactive digital media and described the occurrence of lymph node pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced lymph node pain. On an unknown date, the outcome of the lymph node pain was unknown.   The reporter considered the lymph node pain to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient received the dose of Shingrix and stated that it caused his/her lymph node to hurt. The follow-up would not possible as no contact details were available.
Generalized sz, high pitched cry x 45 min, fever of 103F(r); Then on & off twitches the rest of the Evening; Mom also noted that leg fr knee to thigh swollen w/redness 1/4" dia. around inject site; Still had temp 100-101F;
received the Moderna Monovalent Booster instead of the bivalent vaccine; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine).    No concomitant medications were reported.  It was reported that, the patient received the Moderna Monovalent Booster instead of the bivalent vaccine. The nurse stated that, this happened because the monovalent vaccine with purple border was labeled as booster dose.  No adverse event noted.  No treatment medications were reported.
Felt very uncomfortable, arm really swollen, hard, warm, itchy. Called pharmacist who recommended ice and TYLENOL. Not quite as hard, warm today. Not as painful but has limited movement.
antibiotic for a Sinus infection or an ear infection because it had the lymph nodes swollen; low grade fever that is still going on then 101°F and has not been that high so took Tylenol but didn't make any difference, the fever; here was a rash all over the body, not hands, not face, and not on the feet but on the rest of the; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (antibiotic for a Sinus infection or an ear infection because it had the lymph nodes swollen), RASH (here was a rash all over the body, not hands, not face, and not on the feet but on the rest of the) and PYREXIA (low grade fever that is still going on then 101°F and has not been that high so took Tylenol but didn't make any difference, the fever) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced RASH (here was a rash all over the body, not hands, not face, and not on the feet but on the rest of the). On an unknown date, the patient experienced LYMPHADENOPATHY (antibiotic for a Sinus infection or an ear infection because it had the lymph nodes swollen) and PYREXIA (low grade fever that is still going on then 101°F and has not been that high so took Tylenol but didn't make any difference, the fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (antibiotic for a Sinus infection or an ear infection because it had the lymph nodes swollen), RASH (here was a rash all over the body, not hands, not face, and not on the feet but on the rest of the) and PYREXIA (low grade fever that is still going on then 101°F and has not been that high so took Tylenol but didn't make any difference, the fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment medicines include Antihistamine, Tylenol.
Developed a slight fever late at night the same day f the vaccine. Had chills, was freezing at night, had lots of blankets, electric heater could not feel warm. Did not take anything. Next morning woke up and still felt a little bit of general malaise, took Tylenol and that is it, it was all over in 24 hours.
Blurred vision Uveitis Eye pain (blurred vision, eye soreness, watery, achiness, light sensitive) Eustachian tube dysfunction Loss of hearing in left ear Left facial pain Tinnitus  Sharp pain behind my nose Headache Nausea Fatigue Insomnia Para insomnia Phantosmia insomnia Ageusia  Dysgeusia Cough Sore throat Chills Brain fog Muscle Aches Joint Pain  I took Tylenol, cough drops, and vitamin supplements to treat these symptoms. I am A Positive blood type.
Red rash/hives for approximately 8 weeks after 2nd dose of vaccination, skin itchiness and irritation, skin flare ups, welts. Took Benadryl and Claritin. Rash reappeared 12 days after receiving booster dose of vaccination.
4:45 pm - Pt returned to clinic c/o hives. States he is not having any difficulty breathing. Reports face feels "tingly". Pt shows no apparent distress. Urticarial rash on bilateral UEs and upper back. No erythema or edema of pharynx. Lungs CTA. 4:50 pm Order given for diphenhydramine 50 mg IM and 80 mg (2 mL of 40 mg/mL) Depo Medrol IM now. 5:00 pm, Pt reports feeling a "lump in my throat". EpiPen Auto-Injector administered. 5:20 pm Reports still feels the lump in his throat, but it is no worse. Denies throat itching or difficulty breathing. Denies drowsiness. BP 140/72 in L arm (sitting). Apical pulse 80. Pt alert and oriented x 4. No apparent distress. No erythema or edema of pharynx. Lungs CTA. No spread of urticarial rash. Pt released to drive home. Advised he may continue OTC Benadryl every 4-6 hours (pt reports a supply at home). Pt advised Depo Medrol may increase his blood sugar. Pt advised to call PCP in the morning for f/u and go immediately to ER with difficulty breathing.
rash on both lower legs that was red and itchy that is still there - started 2 days after 1st dose
This is a spontaneous report from a contactable physician received via a sales representative. A female patient of unknown age and ethnicity received a single dose of PREVNAR13 on 08JAN2013. Relevant medical history, concomitant medications, and past drug history were not reported. No other vaccines were administered on the same day and vaccines administered within the last four weeks were unknown. On 08JAN2013, the patient experienced swollen eyes, facial swelling, and the patient's "face got real red". Therapeutic measures received included use of BENADRYL. The patient recovered from the events swollen eyes, facial swelling and "face got real red" on an unspecified date in  JAN2013. Follow-up attempts completed. No further information expected.
Nausea, vomiting, dizziness, hard time focusing, felt like she was spinning. Later hives, difficulty standing, almost past out, lethargic.
Headache, Myalgia, Fatigue Narrative:  Received vaccine on 12-21-20. Came to work the next day, by noon was not feeling well. Headache, myalgia and fatigue. Left work at 2pm - which was 2 hours early. Slept it off, came to work the next day.
Site: Itching at Injection Site-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Hypertension-Medium, Additional Details: bp 175/110 hr 76 and bp 15 min later 158/100 hr 72 and on bp meds
accidentally gave the First dose of the Moderna Covid-19 Vaccine to a 15 year old female patient today; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (accidentally gave the First dose of the Moderna Covid-19 Vaccine to a 15 year old female patient today) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) Unknown. On 25-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (accidentally gave the First dose of the Moderna Covid-19 Vaccine to a 15 year old female patient today). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (accidentally gave the First dose of the Moderna Covid-19 Vaccine to a 15 year old female patient today) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up received on 26-MAY-2021 does not contain any new information.
Shingles vaccine 7/10/2015, Lt. deltoid. Today site is red, indurated, warm to touch and "itchy". Induration 5 x 7 cm. Redness 10 x 12 cm.
2/4/21 7:30pm diarrhea; itching all over body, hives visible to bilateral upper arms, chest, upper back. Benadryl 50mg taken.  2/5/21 awoke at 5am intense itching resumes. No hives, pain all over body, skin hurts; headache with dizziness;  diarrhea; remained in bed all day into evening; ibuprofen and Tylenol taken around the clock.  2/6/21 awoke at 6:30 am itching resumes; headache; joints painful; ibuprofen and Tylenol around the clock 2/7/21 awoke at 6:30 am. Itching resumes, mild headache, ibuprofen and Tylenol throughout the day
Fever x 3 days with left upper arm circumferential cellulitis and swelling and streaking down left lateral chest wall and breast.
Bursitis and tendonitis in left shoulder area.  Diagnosed by doctor on 03/25/2013.  Ice, electric stimulation, chiropractic adjustment.
Soreness in arm and shoulder blade muscle tenderness in her chest. 12/08/09 Prenatal records received for DOS 10/19/09-12/01/09. G4 P1
Patients first dose of the COVID vaccine on 07/15/2022 was charted as pfizer.  The patient signed a consent form but did NOT check which vaccine they wanted, however verbally consented to receiving the Moderna vaccine.  On 08/22/22, patient arrived for 2nd dose, and when nurse asked if it would be Pfizer, same as the first, the patient stated that the first dose should have been Moderna but if the patient got a pfizer vaccine then they were ok with them getting a second dose of pfizer.  The patients parent did not bring in the card either.  Nurse gave 2nd dose at pfizer.  We do not know which brand was truly given first, but if it was moderna, they have now received 1 dose of each brand.  Helpdesk was consulted and they advised us that the patient should receive a third dose of EITHER brand to make the series complete, at least 8 weeks after the 2nd dose.